Crystallization of C-Reactive Protein Following Removal of Associated Lipid-Containing Material by Antiserum to Normal Human Beta Lipoprotein.

1. WOOD HF, McCARTY M, SLATER RJ. The occurrence during acute infections of a protein not normally present in the blood. V. Physical-chemical properties of the C-reactive protein crystallized by a modified technique.. J Exp Med 1954 Jul 1;100(1):71-9.
   pubmed: 13163339doi: 10.1084/jem.100.1.71google scholar: lookup
2. Macleod CM, Avery OT. THE OCCURRENCE DURING ACUTE INFECTIONS OF A PROTEIN NOT NORMALLY PRESENT IN THE BLOOD : II. ISOLATION AND PROPERTIES OF THE REACTIVE PROTEIN.. J Exp Med 1941 Jan 31;73(2):183-90.
   pubmed: 19871071doi: 10.1084/jem.73.2.183google scholar: lookup
3. McCarty M. THE OCCURRENCE DURING ACUTE INFECTIONS OF A PROTEIN NOT NORMALLY PRESENT IN THE BLOOD : IV. CRYSTALLIZATION OF THE C-REACTIVE PROTEIN.. J Exp Med 1947 Apr 30;85(5):491-8.
   pubmed: 19871631doi: 10.1084/jem.85.5.491google scholar: lookup

Citations

1. de Beer FC, Soutar AK, Baltz ML, Trayner IM, Feinstein A, Pepys MB. Low density lipoprotein and very low density lipoprotein are selectively bound by aggregated C-reactive protein.. J Exp Med 1982 Jul 1;156(1):230-42.
   doi: 10.1084/jem.156.1.230pubmed: 7086355google scholar: lookup
2. Fiedel BA, Potempa LA, Frenzke ME, Simpson RM, Gewurz H. Platelet inhibitory effects of CRP preparations are due to a co-isolating low molecular weight factor.. Immunology 1982 Jan;45(1):15-22.
   pubmed: 7056562
3. Walker LC, Tucker DF, Begent RH. Identification of PEG-precipitable serum factor associated with malignant lymphoma as C-reactive protein.. Br J Cancer 1983 Jan;47(1):161-4.
   doi: 10.1038/bjc.1983.20pubmed: 6821631google scholar: lookup
4. Bieber MM, Fuks Z, Kaplan HS. E-rosette inhibiting substance in Hodgkin's disease spleen extracts.. Clin Exp Immunol 1977 Sep;29(3):369-75.
   pubmed: 201408